Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I randomised, double-blind, parallel-group, placebo-controlled, multiple dose ascending study of CK 2127107 in healthy volunteers

Trial Profile

A Phase I randomised, double-blind, parallel-group, placebo-controlled, multiple dose ascending study of CK 2127107 in healthy volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 01 May 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Reldesemtiv (Primary)
  • Indications Muscular atrophy
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Cytokinetics
  • Most Recent Events

    • 30 Nov 2017 According to a Cytokinetics media release, results from this and two other studies (profiles 700242741 and 700247918) are published in Muscle & Nerve Journal "CK-2127107 Amplifies Skeletal Muscle Response to Nerve Activation in Humans".
    • 19 Jun 2015 According to a Cytokinetics media release, results from this and two other studies (profiles 700242100 and 700247918) were presented at the 19th International SMA (Spinal Muscular Atrophy) Researcher Meeting held during the 2015 Annual SMA Conference.
    • 13 Oct 2014 Results published in the Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top